Ikigo cy’Ubushinwa cya NMPA cyemeje ikimenyetso gishya cya Bireociclib: Icyizere gishya cya mbere kuri kanseri y’ibere ya HR+/HER2- iteye imbere

Vuba aha, Ikigo cy’Igihugu cy’Ubuvuzi cy’Ubushinwa (NMPA) cyemeje ikimenyetso gishya cya Bireociclib, umuti mushya wo mu cyiciro cya mbere wakozwe ku giti cyawo na Xuanzhu Biopharmaceutical. Iki kimenyetso gishya ni icyo gukoreshwa hamwe n’umuti ubuza aromatase nk’umuti wa mbere w’imisemburo ku barwayi ba kanseri y’ibere ya HR+/HER2. Iki cyemezo kigaragaza ko Bireociclib ari wo muti wa mbere kandi rukumbi mu Bushinwa uvura kanseri y’ibere ya HR+/HER2—harimo n’ubuvuzi bwa mbere, ubwa kabiri, n’ubwa nyuma—butanga uburyo bushya bwo kuvura abarwayi ku isi yose.

Niba wowe cyangwa abakunzi bawe mushaka uburyo bwiza bwo kuvura kanseri y'ibere, nyamuneka hamagara Ishami Mpuzamahanga ry’Ibitaro bya Oncology bya Beijing mu Karere k’Amajyepfo:

 

- Terefone: 400-880-3716

- WeChat: 17801183037

- Email ①: 100085_010@163.com

- Email ②: myimmnet@163.com

 

 

**Kuva ku murongo wa kabiri kugeza ku murongo wa mbere: Impinduka mu "bice byose" bya Bireociclib**

 

Bireociclib ni umuti mushya wo gukumira indwara za CDK2/4/6. Mbere wemejwe gukoreshwa hamwe na fulvestrant mu kuvura kanseri y'ibere imaze gutera imbere nyuma yo kuvurwa indwara z'imitsi, ndetse no kuvura abarwayi bafite indwara yo kudakira. Kwemezwa kw'iki kimenyetso gishya bitera ikoreshwa ryayo mu kuvura indwara z'imitsi ku rwego rwa mbere, bigatanga ubwishingizi bwuzuye kuva ku kuvurwa bwa mbere kugeza ku kuvura indwara z'imitsi nyuma.

 

Uku kwemezwa gushingiye ku bisubizo by'isesengura ry'agateganyo ry'ubushakashatsi bwa BRIGHT-3. Ubushakashatsi bwagaragaje ko ikigereranyo cy'ubuzima budafite iterambere (PFS) ku itsinda rya Bireociclib hamwe na AI kitaragerwaho, bigaragaza ko imikorere yacyo irambye cyane; ugereranije, PFS ku itsinda ryagenzuwe yari amezi 18.4. Igishimishije kurushaho ni uko igipimo cya PFS cy'imyaka 2 mu itsinda rya Bireociclib cyarenze 60%, naho igipimo cy'ubutabazi bw'ibanze (ORR) cyageze kuri 63.5%, kigera kuri 67.6% ku barwayi bafite ibisebe bipimwa. Aya makuru agaragaza ko Bireociclib ubu igaragaza imikorere myiza cyane mu miti isa nayo.

 

**Uburyo bwo gukora ibintu mu buryo bugezweho: Uburyo bwo guhuza ibikorwa mu buryo butandukanye no kuringaniza imikorere n'umutekano**

 

Umwihariko wa Bireociclib ushingiye ku buryo bwayo bwo gukorana mu buryo butandukanye. Nk'umuti mushya wa CDK2/4/6, ntabwo ibuza gusa CDK4 na CDK6 ku buryo bukomeye ahubwo inabuza CDK2 na CDK9 icyarimwe.

 

- **Gutinda Kurwanya Imiti:** Gukora CDK2 ni imwe mu nzira z'ingenzi zo kurwanya CDK4/6. Mu gukumira CDK2 icyarimwe, Bireociclib ishobora kuzibira neza inzira zo gukwirakwira kw'uturemangingo tw'ibibyimba, bityo bigatinza gutangira kwanga imiti ituruka aho ikomoka.

- **Uburozi buri hasi:** Uburozi bwo mu maraso nka neutropenia yo mu cyiciro cya 3/4, ikunze kugaragara mu miti igabanya CDK4/6, igabanuka cyane iyo umuntu avuwe na Bireociclib. Ibi bivuze ko abarwayi bashobora kwihanganira ubuvuzi neza, bakagabanya ihagarikwa ry’ubuvuzi bitewe n’ingaruka mbi, bityo bigatuma imikorere ikomeza kuba myiza.

 

**Amakuru Agaragaza Ingufu: Intsinzi Rusange y'Uruhererekane rw'Inyigo BRIGHT**

 

Imikorere myiza ya Bireociclib si ikintu cyonyine gihari ahubwo yubakiye ku rufatiro rukomeye rw'uruhererekane rw'ubushakashatsi bwa BRIGHT:

 

- **Inyigo ya BRIGHT-2 (Ubuvuzi bw'umurongo wa kabiri):** Bireociclib hamwe na fulvestrant byageze ku gipimo cya PFS cy'amezi 17.5. Mu kugereranya ibitari ibyo abantu bagereranya, aya makuru ni yo meza cyane.

- **Inyigo ya BRIGHT-1 (Umuti wo mu Munsi wa Nyuma):** Ku barwayi bavuwe mbere cyane kandi barwaye indwara ikomeye yo kudakira, Bireociclib monotherapy yatumye habaho impuzandengo ya PFS y'amezi 11 n'impuzandengo y'amezi 29 yo kubaho muri rusange. Iyi ni na yo ngingo nziza ku isi, igaragaza ko ikora neza cyane mu barwayi bagorwa cyane.

 

**Kuki wahitamo Ishami Mpuzamahanga ry’Ibitaro bya Oncology byo mu Karere k’Amajyepfo ka Beijing?**

 

Ishami Mpuzamahanga ry’Ibitaro bya Oncology byo mu Karere k’Amajyepfo rya Beijing ryiyemeje guhuza udushya ku rwego rw’isi mu bijyanye n’imiti n’ibikoresho by’ubuvuzi byo mu Bushinwa. Nk’umuti ugezweho watangijwe mu Bushinwa, kwemezwa kwa Bireociclib ntikugirira akamaro abarwayi bo mu ngo gusa ahubwo binatanga icyizere gishya ku barwayi mpuzamahanga. Ishami ryacu Mpuzamahanga ritanga abarwayi bo mu mahanga:

 

1. **Ubujyanama mu nzego zitandukanye:** Isuzuma ry'indwara no gutegura gahunda zihariye n'itsinda ry'impuguke zikomeye mu bijyanye na kanseri y'ibere.

2. **Kubona Imiti Igezweho:** Kubona imiti mishya yemewe mu Bushinwa irwanya kanseri, harimo na Bireociclib.

3. **Serivisi yuzuye:** Ubufasha bw'ubuvuzi butangwa rimwe, kuva ku nama y'ibanze no gushyira mu bikorwa gahunda yo kuvura kugeza ku gukurikirana igihe kirekire.

4. **Ubufasha mu rurimi no gutwara abantu:** Ubusemuzi bw'umwuga mu buvuzi no kubona uburyo bwihariye bwo gukemura ibibazo by'ibikoresho ku barwayi mpuzamahanga.

**Twandikire ubu ngubu**

Niba wowe cyangwa abagize umuryango wawe muhanganye na kanseri y'ibere ya HR + / HER2 kandi mukaba mwifuza kumenya niba Bireociclib ishobora kuba uburyo bwiza bwo kuvura, nyamuneka hamagara Ishami Mpuzamahanga ry’Ibitaro bya Oncology bya Beijing mu Karere k’Amajyepfo byihuse. Itsinda ryacu ry’inzobere rizaguha inama zirambuye z’ubuvuzi n’ubufasha bwo gushaka ubuvuzi mu Bushinwa.

- ��� Terefone: 400-880-3716

- ��� WeChat: 17801183037

- ��� Email: 100085_010@163.com or myimmnet@163.com

微信图片 _20241115181717


Igihe cyo kohereza ubutumwa: Werurwe-06-2026